scispace - formally typeset
Open AccessJournal ArticleDOI

Histone deacetylases (HDACs): characterization of the classical HDAC family

Reads0
Chats0
TLDR
In this paper, a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity is presented.
Abstract
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the post-translational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation. Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect. Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones. The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity. SAGE (serial analysis of gene expression) data show that HDACs are generally expressed in almost all tissues investigated. Surprisingly, no major differences were observed between the expression pattern in normal and malignant tissues. However, significant variation in HDAC expression was observed within tissue types. HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis. This challenging field has generated many fascinating results which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation

TL;DR: The application of frequently used small molecule HDAC inhibitors as an approach to attenuate inflammatory responses, and their potential as novel therapeutics are addressed.
Journal ArticleDOI

The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat.

TL;DR: This review provides an overview of current knowledge, progress, and molecular mechanisms of HDACIs, covering a period from 2011 until 2015.
Journal ArticleDOI

Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation

TL;DR: The results suggest that short-chain fatty acids, especially butyrate, induce TJ permeability changes through LOX activation through histone acetylation.
Patent

Histone deacetylases, and uses related thereto

TL;DR: In this paper, the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and thus in transcription and translation was made.
Journal ArticleDOI

Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma

TL;DR: It is demonstrated here that miR-29b specifically targets HDAC4 and highlighted that both molecules are involved in a functional loop, shedding light on a novel epigenetic circuitry regulating multiple myeloma cell growth and survival and open new avenues for miR -29b–based epi-therapeutic approaches in the treatment of this malignancy.
References
More filters
Journal ArticleDOI

The language of covalent histone modifications.

TL;DR: It is proposed that distinct histone modifications, on one or more tails, act sequentially or in combination to form a ‘histone code’ that is, read by other proteins to bring about distinct downstream events.
Journal ArticleDOI

The fundamental role of epigenetic events in cancer

TL;DR: This review discusses patterns of DNA methylation and chromatin structure in neoplasia and the molecular alterations that might cause them and/or underlie altered gene expression in cancer.
Journal ArticleDOI

HDAC6 is a microtubule-associated deacetylase

TL;DR: The results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription, including microtubule-dependent cell motility.
Journal ArticleDOI

Histone deacetylases and cancer: causes and therapies.

TL;DR: Together, histone acetyltransferases and histone deacetylases determine the acetylation status of histones, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumours cells by altering the transcription of a small number of genes.
Journal ArticleDOI

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

TL;DR: Results clearly indicate that TSA is a potent and specific inhibitor of the histone deacetylase and that the in vivo effect of TSA on cell proliferation and differentiation can be attributed to the inhibition of the enzyme.
Related Papers (5)